Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App





Bosch Demonstrates Vivalytic All-In-One PCR Analyzer at MEDICA 2022

By LabMedica International staff writers
Posted on 16 Nov 2022

Bosch Healthcare Solutions (Waiblingen, Germany) is demonstrating the Vivalytic Analyzer, the all-in-one solution for PCR rapid tests, at MEDICA 2022. More...

Vivalytic is a universal platform for molecular diagnostics, which enables various laboratory tests to be performed swiftly and in a fully automated manner. The platform unites a wide spectrum of tests with a varying number of clinically relevant parameters on one device. The Vivalytic Analyzer enables fully automated PCR testing in laboratory quality – fast and directly at the point of care. The system consists of just a compact analysis device and cartridges the size of a smartphone. This enables rapid PCR tests to be carried out directly on site.

The Vivalytic Analyzer unites a wide variety of innovative technologies in one compact device. With only a touch display, a slot for inserting the test cartridge, a button and a scanner, the system is very intuitive to use. Its minimalistic design makes the Vivalytic system very user-friendly: medical professionals require only minimal training to be able to safely operate the Analyzer. Different types of samples can be tested fully automated with the Vivalytic Analyzer and its innovative technology reduces the need for manual preparation. The Analyzer takes over this task before the analysis and evaluation takes place. With its compact dimensions, the Vivalytic Analyzer can be used anywhere – be it in the laboratory, on the hospital ward or directly at the point of care.

Related Links:
Bosch Healthcare Solutions


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
POC Immunoassay Analyzer
Procise DX
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: iStock

AMP 2026 Underscores Molecular Testing’s Role in Precision Medicine for Women’s Health

Advances in molecular diagnostics are creating new opportunities to improve the detection of sexually transmitted infections, identify antibiotic resistance, and assess cancer recurrence risk in women.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.